Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
1-[1,1'-Biphenyl]-4-yl-2-(2,3-dihydro-9H-imidazo[1,2-a]benzimidazol-9-yl)-ethanone hydrobromide is an inhibitor of TCF-dependent transcription. CCT 031374 was also shown to increase turnover of β-catenin.